Personalis

Q2 FY2026 EarningsQ2 FY26 outperformed consensus expectations on the top line, with revenue of $22.4M exceeding the $16.8M forecast by 33%. While clinical diagnostic revenue surged 442% YoY, the company reported a larger-than-expected net loss of $31.7M ($0.30 per share) vs. the $27.6M loss anticipated, driven by significant increases in R&D and SG&A expenses. Following the merger agreement with Tempus AI, the company has suspended future financial guidance.